Human Embryonic Stem Cells (HESC) Market 2019 | Analyzing The Impact Followed By Restraints, Opportunities And Projected Developments | DataIntelo -…

DataIntelo, one of the worlds prominent market research firms has released a new report on Global Human Embryonic Stem Cells (HESC) Market. The report contains crucial insights on the market which will support the clients to make the right business decisions. This research will help both existing and new aspirants for Human Embryonic Stem Cells (HESC) market to figure out and study market needs, market size, and competition. The report talks about the supply and demand situation, the competitive scenario, and the challenges for market growth, market opportunities, and the threats faced by key players.

The report also includes the impact of ongoing global crisis i.e. COVID-19 on the Human Embryonic Stem Cells (HESC) market and what the future holds for it. The published report is designed using a vigorous and thorough research methodology and DataIntelo is also known for its data accuracy and granular market reports.

You can buy the report @ https://dataintelo.com/checkout/?reportId=94347

A complete analysis of the competitive scenario of the Human Embryonic Stem Cells (HESC) market is depicted by the report. The report has a vast amount of data about the recent product and technological developments in the markets. It has a wide spectrum of analysis regarding the impact of these advancements on the markets future growth, wide-range of analysis of these extensions on the markets future growth.

Human Embryonic Stem Cells (HESC) market report tracks the data since 2015 and is one of the most detailed reports. It also contains data varying according to region and country. The insights in the report are easy to understand and include pictorial representations. These insights are also applicable in real-time scenarios.

Request Free Sample Report @ https://dataintelo.com/request-sample/?reportId=94347

Components such as market drivers, restraints, challenges, and opportunities for Human Embryonic Stem Cells (HESC) are explained in detail. Since the research team is tracking the data for the market from 2015, therefore any additional data requirement can be easily fulfilled.

Some of the prominent companies that are covered in this report:

ESI BIOThermo FisherBioTimeMilliporeSigmaBD BiosciencesAstellas Institute of Regenerative MedicineAsterias BiotherapeuticsCell Cure NeurosciencesPerkinElmerTakara BioCellular Dynamics InternationalReliance Life SciencesResearch & Diagnostics SystemsSABiosciencesSTEMCELL TechnologiesStemina Biomarker DiscoveryTakara BioTATAA BiocenterUK Stem Cell BankViaCyteVitrolife

*Note: Additional companies can be included on request

The industry looks to be fairly competitive. To analyze any market with simplicity the market is fragmented into segments, such as its product type, application, technology, end-use industry, etc. Segmenting the market into smaller components helps in understanding the dynamics of the market with more clarity. Data is represented with the help of tables and figures that consist of a graphical representation of the numbers in the form of histograms, bar graphs, pie charts, etc. Another key component that is included in the report is the regional analysis to assess the global presence of the Human Embryonic Stem Cells (HESC) market.

Following is the gist of segmentation:

By Application:

ResearchClinical TrialsOthers

By Type:

Totipotent Stem CellsPluripotent Stem CellsUnipotent Stem Cells

By Geographical Regions

Asia Pacific: China, Japan, India, and Rest of Asia PacificEurope: Germany, the UK, France, and Rest of EuropeNorth America: The US, Mexico, and CanadaLatin America: Brazil and Rest of Latin AmericaMiddle East & Africa: GCC Countries and Rest of Middle East & Africa

You can also go for a yearly subscription of all the updates on the Human Embryonic Stem Cells (HESC) market.

Reasons you should buy this report:

Below is the TOC of the report:

Executive Summary

Assumptions and Acronyms Used

Research Methodology

Human Embryonic Stem Cells (HESC) Market Overview

Human Embryonic Stem Cells (HESC) Supply Chain Analysis

Human Embryonic Stem Cells (HESC) Pricing Analysis

Global Human Embryonic Stem Cells (HESC) Market Analysis and Forecast by Type

Global Human Embryonic Stem Cells (HESC) Market Analysis and Forecast by Application

Global Human Embryonic Stem Cells (HESC) Market Analysis and Forecast by Sales Channel

Global Human Embryonic Stem Cells (HESC) Market Analysis and Forecast by Region

North America Human Embryonic Stem Cells (HESC) Market Analysis and Forecast

Latin America Human Embryonic Stem Cells (HESC) Market Analysis and Forecast

Europe Human Embryonic Stem Cells (HESC) Market Analysis and Forecast

Asia Pacific Human Embryonic Stem Cells (HESC) Market Analysis and Forecast

Middle East & Africa Human Embryonic Stem Cells (HESC) Market Analysis and Forecast

Competition Landscape

If you have any questions on this report, please reach out to us @ https://dataintelo.com/enquiry-before-buying/?reportId=94347

About DataIntelo:

DataIntelo has a vast experience in designing tailored market research reports in various industry verticals. We also have an urge to provide complete client satisfaction. We cover in-depth market analysis, which consists of producing lucrative business strategies for the new entrants and the emerging players of the market. We make sure that each report goes through intensive primary, secondary research, interviews, and consumer surveys before final dispatch. Our company provides market threat analysis, market opportunity analysis, and deep insights into the current market scenario.

We invest in our analysts to ensure that we have a full roster of experience and expertise in any field we cover. Our team members are selected for stellar academic records, specializations in technical fields, and exceptional analytical and communication skills. We also offer ongoing training and knowledge sharing to keep our analysts tapped into industry best practices and loaded with information.

Contact Info:

Name: Alex Mathews

Address: 500 East E Street, Ontario,

CA 91764, United States.

Phone No: USA: +1 909 545 6473

Email:[emailprotected]

Website:https://dataintelo.com

Read the rest here:

Human Embryonic Stem Cells (HESC) Market 2019 | Analyzing The Impact Followed By Restraints, Opportunities And Projected Developments | DataIntelo -...

Read more
Stem Cell Manufacturing Market Analysis by Industry Size, Share, Key Drivers, Growth Factors, Demands, Top Manufacturers- Merck Group, Becton,…

A new research document is added in DBMR database of 350 pages, titled as Stem Cell Manufacturing Market with detailed analysis, Competitive landscape, forecast and strategies. This overview includes the market definition, key applications of the product, and the recent manufacturing technology employed for such production. This also report provide the details about industry overview and analysis about size, share, growth, trend, demand, outlook, classification revenue details, competitive scenario, industry analysis, Markets forecast, manufacturers with development trends and forecasts 2027. This research refines variations of the Stem Cell Manufacturing market to help you in planning the general strategy. The document is provided in readily possible records that uncover tables, charts, figures, structured presentations, pie graphs, and other visual portrayals.

Stem cell manufacturing is forecasted to grow at CAGR of 6.42% to an anticipated value of USD 18.59 billion by 2027 with factors like rising awareness towards diseases like cancer, degenerative disorders and hematopoietic disorders is driving the growth of the market in the forecast period of 2020-2027.

Download Exclusive Sample (350 Pages PDF) Report: To Know the Impact of COVID-19 on thisIndustry@https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-stem-cell-manufacturing-market&AB

Stem cell manufacturing has shown an exceptional penetration in North America due to increasing research in stem cell. Increasing research and development activities in biotechnology and pharmaceutical sector is creating opportunity for the stem cell manufacturing market.

The Global Stem Cell Manufacturing Market 2020 research provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Global Stem Cell Manufacturing Market Share analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed.

Global Stem Cell Manufacturing Market Segematation By Product (Stem Cell Line, Instruments, Culture Media, Consumables), Application (Research Applications, Clinical Applications, Cell and Tissue Banking), End Users (Hospitals and Surgical Centers, Pharmaceutical and Biotechnology Companies, Clinics, Community Healthcare, Others)

List of TOP KEY PLAYERS in Stem Cell Manufacturing Market Report are

Thermo Fisher ScientificMerck KGaABDJCR Pharmaceuticals Co., LtdOrganogenesis IncOsirisVericel CorporationAbbVie IncAM-Pharma B.VANTEROGEN.CO.,LTDAstellas Pharma IncBristol-Myers Squibb CompanyFUJIFILM Cellular Dynamics, IncRHEACELL GmbH & Co. KGTakeda Pharmaceutical Company LimitedTeva Pharmaceutical Industries LtdViaCyte,IncVistaGen Therapeutics IncGlaxoSmithKline plc..

Complete Report is Available (Including Full TOC, List of Tables & Figures, Graphs, and Chart)@https://www.databridgemarketresearch.com/toc/?dbmr=global-stem-cell-manufacturing-market&AB

The report can help to understand the market and strategize for business expansion accordingly. In the strategy analysis, it gives insights from marketing channel and market positioning to potential growth strategies, providing in-depth analysis for new entrants or exists competitors in the Stem Cell Manufacturing industry. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins. For each manufacturer covered, this report analyzes their Stem Cell Manufacturing manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The Global Stem Cell Manufacturing Market Trends, development and marketing channels are analysed. Finally, the feasibility of new investment projects is assessed and overall research conclusions offered.

Global Stem Cell Manufacturing Market Scope and Market Size

Stem cell manufacturing market is segmented on the basis of product, application and end users. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

Based on product, the stem cell manufacturing market is segmented into stem cell lines, instruments, culture media and consumables. Stem cell lines are further segmented into induced pluripotent stem cells, embryonic stem cells, multipotent adult progenitor stem cells, mesenchymal stem cells, hematopoietic stem cells, neural stem cells. Instrument is further segmented into bioreactors and incubators, cell sorters and other instruments.

On the basis of application, the stem cell manufacturing market is segmented into research applications, clinical applications and cell and tissue banking. Research applications are further segmented into drug discovery and development and life science research. Clinical applications are further segmented into allogenic stem cell and autologous stem cell therapy.

On the basis of end users, the stem cell manufacturing market is segmented into hospitals and surgical centers, pharmaceutical and biotechnology companies, research institutes and academic institutes, community healthcare, cell banks and tissue banks and others.

Healthcare Infrastructure growth Installed base and New Technology Penetration

Stem cell manufacturing market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for stem cell manufacturing market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the stem cell manufacturing market. The data is available for historic period 2010 to 2018.

The Global Stem Cell Manufacturing Market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of stem cell manufacturing market for global, Europe, North America, Asia Pacific and South America.

Key Insights in the report:

Historical and current market size and projection up to 2025

Market trends impacting the growth of the global taste modulators market

Analyze and forecast the taste modulators market on the basis of, application and type.

Trends of key regional and country-level markets for processes, derivative, and applicationCompany profiling of key players which includes business operations, product and services, geographic presence, recent developments and key financial analysis

For More Information or Query or Customization Before Buying, Visit @https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-stem-cell-manufacturing-market&AB

Opportunities in the market

To describe and forecast the market, in terms of value, for various segments, by region North America, Europe, Asia Pacific (APAC), and Rest of the World (RoW)

The key findings and recommendations highlight crucial progressive industry trends in the Stem Cell manufacturing Market, thereby allowing players to develop effective long term strategies

To strategically profile key players and comprehensively analyze their market position in terms of ranking and core competencies, and detail the competitive landscape for market leadersExtensive analysis of the key segments of the industry helps in understanding the trends in types of point of care test across Europe.

To get a comprehensive overview of the Stem Cell manufacturing market.

With tables and figures helping analyses worldwide Global Stem Cell Manufacturing Market Forecast this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.There are 15 Chapters to display the Stem Cell Manufacturing market.

Chapter 1, About Executive Summary to describe Definition, Specifications and Classification of Stem Cell Manufacturing market, By Product Type, by application, by end users and regions.

Chapter 2, objective of the study.

Chapter 3, to display Research methodology and techniques.

Chapter 4 and 5, to show the Stem Cell Manufacturing Market Analysis, segmentation analysis, characteristics;

Chapter 6 and 7, to show Five forces (bargaining Power of buyers/suppliers), Threats to new entrants and market condition;

Chapter 8 and 9, to show analysis by regional segmentation[North America, Europe, Asia-Pacific etc ], comparison, leading countries and opportunities; Regional Marketing Type Analysis, Supply Chain Analysis

Chapter 10, to identify major decision framework accumulated through Industry experts and strategic decision makers;

Chapter 11 and 12, Stem Cell Manufacturing Market Trend Analysis, Drivers, Challenges by consumer behavior, Marketing Channels

Chapter 13 and 14, about vendor landscape (classification and Market Ranking)

Chapter 15, deals with Stem Cell Manufacturing Market sales channel, distributors, Research Findings and Conclusion, appendix and data source.

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia or Oceania [Australia and New Zealand]

Contact Us:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email:Corporatesales@databridgemarketresearch.com

See the original post here:

Stem Cell Manufacturing Market Analysis by Industry Size, Share, Key Drivers, Growth Factors, Demands, Top Manufacturers- Merck Group, Becton,...

Read more
Stem Cells Market is Expected to Thrive at Impressive CAGR by 2025 – The Haitian-Caribbean News Network

This report studies the Stem Cells market size (value and volume) by players, regions, product types and end industries, history data 2013-2017 and forecast data 2018-2025; This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porters Five Forces Analysis.

Request Sample copy of this report athttps://www.precisionbusinessinsights.com/request-sample?product_id=30511

Stem cells are a class of undifferentiated cells that are able to differentiate into specialized cell types. Commonly, stem cells come from two main sources: Embryos formed during the blastocyst phase of embryological development (embryonic stem cells) and Adult tissue (adult stem cells).

Both types are generally characterized by their potency, or potential to differentiate into different cell types (such as skin, muscle, bone, etc.).

Stem Cells market, by technology, is Cell Acquisition, Cell Production, Cryopreservation, Expansion, and Sub-Culture. Stem Cell Therapy in China is not mature, so in this report we mainly cover Stem Cell Banking market.

Stem Cells market, by technology, is Cell Acquisition, Cell Production, Cryopreservation, Expansion, and Sub-Culture. Stem Cell Therapy in China is not mature, so in this report we mainly cover Stem Cell Banking market.

RequestCustomization copy of this report athttps://www.precisionbusinessinsights.com/request-customisation?product_id=30511

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Stem Cells in these regions, from 2013 to 2025, covering

North America (United States, Canada and Mexico)

Europe (Germany, UK, France, Italy, Russia and Turkey etc.)

Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)

South America (Brazil etc.)

Middle East and Africa (Egypt and GCC Countries)

The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in this market include

CCBC

Vcanbio

Boyalife

Beikebiotech

By the product type, the market is primarily split into

Umbilical Cord Blood Stem Cell

Embryonic Stem Cell

Adult Stem Cell

Other

By the end users/application, this report covers the following segments

Diseases Therapy

Healthcare

We can also provide the customized separate regional or country-level reports, for the following regions:

North America

United States

Canada

Mexico

Asia-Pacific

China

India

Japan

South Korea

Australia

Indonesia

Singapore

Malaysia

Philippines

Thailand

Vietnam

Rest of Asia-Pacific

Europe

Germany

France

UK

Italy

Spain

Russia

Rest of Europe

Central & South America

Brazil

Rest of Central & South America

Middle East & Africa

GCC Countries

Turkey

Egypt

South Africa

Rest of Middle East & Africa

The study objectives of this report are:

To study and analyze the global Stem Cells market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.

To understand the structure of Stem Cells market by identifying its various subsegments.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

Focuses on the key global Stem Cells manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

To analyze the Stem Cells with respect to individual growth trends, future prospects, and their contribution to the total market.

To project the value and volume of Stem Cells submarkets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.

About Us:

Precision Business Insights is one of the leading market research and management consulting firm, run by a group of seasoned and highly dynamic market research professionals with a strong zeal to offer high-quality insights. We at Precision Business Insights are passionate about market research and love to do the things in an innovative way. Our team is a big asset for us and great differentiating factor. Our company motto is to address client requirements in the best possible way and want to be a part of our client success. We have a large pool of industry experts and consultants served a wide array of clients across different verticals. Relentless quest and continuous endeavor enable us to make new strides in market research and business consulting arena.

Contact Us:

[emailprotected]

PH +1-866-598-1553

View original post here:

Stem Cells Market is Expected to Thrive at Impressive CAGR by 2025 - The Haitian-Caribbean News Network

Read more
This Date in UCSF History: Election Offers Mixed Bag of Results – Synapse

Originally published in Synapse on Nov. 30, 2006.Tobacco tax propositions in California, Missouri and South Dakota failed in the November election. However, Arizona passed an increase of 80 cents (total tax 97 cents) to their cigarette tax.

Arizona's tax will fund health and education programs for children ages five and younger, including programs to help improve childhood immunizations and to reduce infant mortality rates.

Californians rejected the tax that would have funded Emergency Department services, expanded health programs for low-income children, provided funding nursing education to help reduce the impact of the projected nursing shortage, funded cancer research, and tobacco cessation and prevention programs.

One of the most effective advertisements opposing the tax featured Dr. LaDonna White from the "Golden State Medical Association," the California affiliate of the National Medical Association representing African American physicians.

In a news segment she said their opposition was based on a loophole in the proposition that exempted hospitals from some anti-trust laws that might result in hospitals limiting competition and driving up prices and insurance premiums.

Missouri's opponents to the tax, such as convenience stores and tobacco companies, successfully convinced voters that the measure unfairly targeted smokers and that providers who treat Medicaid beneficiaries and uninsured residents would get most of the revenue rather than smoking cessation programs.

South Dakotans defeated their one dollar tobacco tax increase based on arguments that it unfairly targeted smokers and it would have reduced tobacco tax revenue for the state because of the decrease in sales of tobacco tax.

This measure included a promise to divide any excess revenue to reduce property taxes and it still failed.

Other health measures decided by voters

Oregon voters passed a law to expand a state prescription drug program to cover all state residents without coverage regardless of age or income.

This is an expansion of Oregon's program which currently provides 30% to 60% discounts on medication to about 150,000 residents without pharmaceutical coverage who are over 55 years of age and who have an annual income of $18,130 or less.

Oregon voters defeated a measure that would have required physicians to notify a parent at least 48 hours before performing an abortion on a minor between the ages of 15 and 17.

California defeated Proposition 85, a measure requiring physicians to notify parents before performing abortions on minors.

The proposition was similar to Prop. 73 which was defeated in 2005. Planned Parenthood was the largest contributor to the No on 85 (and no on 73) campaigns and now must recover from two expensive campaigns.

South Dakota voters rejected a law that had passed the state legislature that would have banned all abortions in the state except to save a pregnant woman's life.

The state law had been signed by Governor Mike Rounds (R) and would have made it a felony to perform an abortion in South Dakota.

Physicians convicted of performing an abortion would have faced a minimum of five years in prison and a $5,000 fine. The vote was 55% to 45% to reject ban.

In Missouri, voters approved measure that would amend the state constitution to ensure that stem cell research, permitted under federal law, is protected in the state, however, it would prohibit cloning.

Women's health policies play important role in Democratic victories Four U.S. Senate races were won by Democrats where abortion rights and stem cell research were key issues.

In Florida, the state where President Bush's brother is governor, Bill Nelson (D) defeated Representative Katherine Harris (R) (famous for her role in the 2000 Presidential election) in the race for U.S. Senate.

The Miami Herald reported that Harris said not electing Christians was "legislating sin, such as abortion rights."

She also opposed human embryonic stem cell research (reported by Kaiser Daily Women's Health Policy Report 9/6). Representative Ben Cardin (D) won the Maryland U.S. Senate race defeating statewide office holder Michael Steel (R).

Steel described stem cell research as the "destruction of human life" and compared it to Nazi experimentation on Jewish people during the Holocaust (a statement he later apologized for and modified his position to support research that allows scientists to extract cells without destroying the embryo).

In Missouri, the Democratic candidate for U.S. Senate Claire McCaskill, who wants to keep early abortion safe and legal, also supports a ban on late term abortions and supports parental notification, ousted U.S. Senator Jim Talent, who would allow abortion only to protect a pregnant woman's life or in the case of rape or incest.

Key in this race was the ballot measure permitting stem cell research in the state constitution, which McCaskill supported and Talent opposed.

The Democratic majority in both the U.S. House and Senate, means that Congress is likely to again pass stem cell research legislation and risk a second Bush veto, however state victories like this one are building the momentum for broader support of stem cell research.

See the article here:

This Date in UCSF History: Election Offers Mixed Bag of Results - Synapse

Read more
Stem Cell Therapy Market Research Report Forecast to 2029 (Includes Business Impact of COVID-19) – Cheshire Media

Trusted Business Insights answers what are the scenarios for growth and recovery and whether there will be any lasting structural impact from the unfolding crisis for the Stem Cell Therapy market.

Trusted Business Insights presents an updated and Latest Study on Stem Cell Therapy Market 2020-2029. The report contains market predictions related to market size, revenue, production, CAGR, Consumption, gross margin, price, and other substantial factors. While emphasizing the key driving and restraining forces for this market, the report also offers a complete study of the future trends and developments of the market.The report further elaborates on the micro and macroeconomic aspects including the socio-political landscape that is anticipated to shape the demand of the Stem Cell Therapy market during the forecast period (2020-2029).It also examines the role of the leading market players involved in the industry including their corporate overview, financial summary, and SWOT analysis.

Get Sample Copy of this Report @ Stem Cell Therapy Market Research Report Forecast to 2029 (Includes Business Impact of COVID-19)

Abstract, Snapshot, Market Analysis & Market Definition: Stem Cell Therapy MarketIndustry / Sector Trends

Stem Cell Therapy Market size was valued at USD 7.8 billion in 2018 and is expected to witness 10.2% CAGR from 2019 to 2025.

U.S. Stem Cell Therapy Market Size, By Type, 2018 & 2025 (USD Million)

Rising prevalence of chronic diseases will positively impact the stem cell therapy market growth. Cardiovascular diseases, neurological disorders and other chronic conditions have resulted in high mortality over past few years. Conventional therapeutic methods and treatments are currently replaced due to lack of efficiency and efficacy. Recently developed stem cell therapies are capable of replacing defective cells to treat diseases that has reduced morbidity drastically. Therefore, people have now started relying on stem cell therapy that has long term positive effects.

Advancements in stem cell therapy in developed regions such as North America and Europe have boosted the industry growth. Since past few years, there have been several researches carried out for stem cell therapy. Currently developed stem cell therapies have shown positive outcomes in treatment of leukemia. Similarly, due to advancements in regenerative medicine, several other chronic conditions such as muscular dystrophy and cardiovascular diseases also have been cured. Aforementioned factors have surged the industry growth. However, high cost of allogenic stem cell therapy may hamper the industry growth to some extent.

Market Segmentation, Outlook & Regional Insights: Stem Cell Therapy Market

Stem Cell Therapy Market, By Type

Allogenic stem cell therapy segment held around 39% revenue share in 2018 and it is anticipated to grow substantially during the analysis timeframe. Allogenic stem cell is available as off the shelf therapy and it is easily scalable that helps in providing treatment without delay. Moreover, the procedure includes culturing donor-derived immunocompetent cells that are highly effective in treatment of several diseases. Stem cells obtained in allogenic therapy are free of contaminating tumor cells. This reduces risk for disease recurrence that will surge its demand thereby, stimulating segment growth.

Autologous stem cell therapy segment is estimated to witness 10.1% growth over the forthcoming years. People usually prefer autologous stem cell therapy as it has minimum risk of immunological rejection. However, on introduction of allogenic stem cell therapy, demand for autologous stem cell therapy has declined as it is difficult to scale up. However, there are concerns regarding risk of cross contamination during large scale manufacturing of autologous stem cell lines that will impede segmental growth to some extent.

Stem Cell Therapy Market, By Application

The neurology segment was valued at around USD 1.6 billion in 2018 and it is estimated that it will witness significant growth over the forthcoming years. Stem cells are used to replenish the disrupted neurological cells that help in quick patient recovery. Pluripotent stem cells provide a replacement for cells and tissues to treat Alzheimers, Parkinsons disease, cerebral palsy, amyotrophic lateral sclerosis, and other neurodegenerative diseases. Thus, the pivotal role of stem cells in treating the life-threatening neurological condition will escalate segment growth.

The cardiovascular segment will witness 10% growth over the analysis timeframe. Considerable segmental growth can be attributed to development in stem cell therapies that have enhanced recovery pace in patients suffering from cardiovascular diseases. Recently developed allogeneic stem cell therapies are efficient and easily available that have reduced the mortality rates in cardiovascular patients. Above mentioned factors will propel cardiovascular segment growth in near future.

Stem Cell Therapy Market, By End-users

The hospital segment held over 56% revenue share in 2018 and it is anticipated to grow significantly in near future. The rising preference for stem cell therapies offered by hospitals proves beneficial for business growth. Hospitals have affiliations with research laboratories and academic institutes that carry out research activities for developing stem cell therapies. On the introduction and approval of any novel stem therapy, hospitals implement it immediately. Associations with research and academic institutes further help hospitals to upgrade its stem cell treatment offerings that positively impact the segmental growth.

The clinics segment is expected to grow at around 10% during the forecast timeframe. Clinics specializing in providing stem cell therapies are well-equipped with advanced medical devices and superior quality reagents required for imparting stem cell therapies. However, as clinics offer specialized stem cell therapies, their treatment cost is much higher as compared to hospitals that may reduce its preference.

Stem Cell Therapy Market, By Region

North America stem cell therapy market held around 41.5% revenue share in 2018 and it is estimated to grow substantially in near future. Increasing the adoption of novel stem cell therapies will prove beneficial for regional market growth. Moreover, favorable government initiatives have a positive impact on regional market growth. For instance, the government of Canada has initiated Strategic Innovation Fund Program that invests in research activities carried out for stem cell therapies enabling development in stem cell therapy. Above mentioned factors are expected to drive the North America market growth.

Asia Pacific stem cell therapy market is anticipated to witness 10.8% growth in the near future owing to increasing awareness amongst people pertaining to the benefits of advanced stem cell therapies. Additionally, favorable initiatives undertaken by several organizations will promote industry players to come up with innovative solutions. For instance, according to Pharma Focus Asia, members of the Asia-Pacific Economic Cooperation collaborated with Life Sciences Innovation Forum to involve professionals having expertise in stem cell therapies from academia and research centers to promote developments in stem cell research. Thus, growing initiatives by organizations ensuring the availability of new stem cell therapies will foster regional market growth.

Latin America Stem Cell Therapy Market Size, By Country, 2025 (USD Million)

Key Players, Recent Developments & Sector Viewpoints: Stem Cell Therapy Market

Key industry players in the stem cell therapy market include Astellas Pharma Inc, Cellectis, Celyad, Novadip Biosciences, Gamida Cell, Capricor Therapeutics, Cellular Dynamics, CESCA Therapeutics, DiscGenics, OxStem, Mesoblast Ltd, ReNeuron Group, and Takeda Pharmaceuticals. Chief industry players implement several initiatives such as mergers and acquisitions to sustain market competition. Also, receiving approvals for stem cell therapy products from regulatory authorities fosters the companys growth. For instance, in March 2018, the European Commission approved Takedas Alofisel that is off-the-shelf stem cell therapy. Product approval will help the company to gain a competitive advantage and capture market share.

Stem Cell Therapy Industry Viewpoint

The stem cells industry can be traced back to the 1950s. In 1959 first animals were made by in-vitro fertilization by preserving the stem cells. Till 2000, research was being carried out on stem cells to study its therapeutic effect. In 2000, fund allocations were made to research on cells derived from aborted human fetuses. In the same year, scientists derived human embryonic stem cells from the inner cell mass of blastocytes. Later, in 2010, clinical trials for human embryonic stem cell-based therapy were initiated. As technology progressed, stem cell therapy for treating cancer was developed. However, due to ethical issues, the use of stem cells for curing diseases witnessed slow growth for a few years. But as the regulatory scenario changed, people started preferring stem cell therapies due to its better efficacy. Stem cell therapy is in the developing stage and has numerous growth opportunities in developing economies with a high prevalence of chronic diseases.

Key Industry Development

In September 2020, Takeda Pharmaceutical Company Limited announced the expansion of its cell therapy manufacturing capabilities with the opening of a new 24,000 square-foot R&D cell therapy manufacturing facility at its R&D headquarters in Boston, Massachusetts. The facility provides end-to-end research and development capabilities and will accelerate Takedas efforts to develop next-generation cell therapies, initially focused on oncology with the potential to expand into other therapeutic areas.

The R&D cell therapy manufacturing facility will produce cell therapies for clinical evaluation from discovery through pivotal Phase 2b trials. The current Good Manufacturing Practices (cGMP) facility is designed to meet all U.S., E.U., and Japanese regulatory requirements for cell therapy manufacturing to support Takeda clinical trials around the world.

The proximity and structure of Takedas cell therapy teams allow them to quickly apply what they learn across a diverse portfolio of next-generation cell therapies including CAR NKs, armored CAR-Ts, and gamma delta T cells. Insights gained in manufacturing and clinical development can be quickly shared across global research, manufacturing, and quality teams, a critical ability in their effort to deliver potentially transformative treatments to patients as fast as possible.

Takeda and MD Anderson are developing a potential best-in-class allogeneic cell therapy product (TAK-007), a Phase 1/2 CD19-targeted chimeric antigen receptor-directed natural killer (CAR-NK) cell therapy with the potential for off-the-shelf use being studied in patients with relapsed or refractory non-Hodgkins lymphoma (NHL) and chronic lymphocytic leukemia (CLL). Two additional Phase 1 studies of Takeda cell therapy programs were also recently initiated: 19(T2)28z1xx CAR T cells (TAK-940), a next-generation CAR-T signaling domain developed in partnership with Memorial Sloan Kettering Cancer Center (MSK) to treat relapsed/refractory B-cell cancers, and a cytokine and chemokine armored CAR-T (TAK-102) developed in partnership with Noile-Immune Biotech to treat GPC3-expressing previously treated solid tumors.

Takedas Cell Therapy Translational Engine (CTTE) connects clinical translational science, product design, development, and manufacturing through each phase of research, development, and commercialization. It provides bioengineering, chemistry, manufacturing, and control (CMC), data management, analytical, and clinical and translational capabilities in a single footprint to overcome many of the manufacturing challenges experienced in cell therapy development.

Key Insights Covered: Exhaustive Stem Cell Therapy Market

1. Market size (sales, revenue and growth rate) of Stem Cell Therapy industry.

2. Global major manufacturers operating situation (sales, revenue, growth rate and gross margin) of Stem Cell Therapy industry.

3. SWOT analysis, New Project Investment Feasibility Analysis, Upstream raw materials and manufacturing equipment & Industry chain analysis of Stem Cell Therapy industry.

4. Market size (sales, revenue) forecast by regions and countries from 2019 to 2025 of Stem Cell Therapy industry.

Research Methodology: Stem Cell Therapy Market

Looking for more? Check out our repository for all available reports on Stem Cell Therapy in related sectors.

Quick Read Table of Contents of this Report @ Stem Cell Therapy Market Research Report Forecast to 2029 (Includes Business Impact of COVID-19)

Trusted Business InsightsShelly ArnoldMedia & Marketing ExecutiveEmail Me For Any ClarificationsConnect on LinkedInClick to follow Trusted Business Insights LinkedIn for Market Data and Updates.US: +1 646 568 9797UK: +44 330 808 0580

See the original post:

Stem Cell Therapy Market Research Report Forecast to 2029 (Includes Business Impact of COVID-19) - Cheshire Media

Read more
Stem Cell Assay to Register Substantial Expansion by 2026| Merck, Thermo Fisher Scientific, GE Healthcare – The Haitian-Caribbean News Network

The global Stem Cell Assay market is broadly analyzed in this report that sheds light on critical aspects such as the vendor landscape, competitive strategies, market dynamics, and regional analysis. The report helps readers to clearly understand the current and future status of the global Stem Cell Assay market. The research study comes out as a compilation of useful guidelines for players to secure a position of strength in the global Stem Cell Assay market. The authors of the report profile leading companies of the global Stem Cell Assay market, such as Merck, Thermo Fisher Scientific, GE Healthcare, Agilent Technologies, Bio-Rad Laboratories, Promega, Cell Biolabs, PerkinElmer, Miltenyi Biotec, HemoGenix, Bio-Techne, STEMCELL They provide details about important activities of leading players in the competitive landscape.

The report predicts the size of the global Stem Cell Assay market in terms of value and volume for the forecast period 2019-2026. As per the analysis provided in the report, the global Stem Cell Assay market is expected to rise at a CAGR of XX % between 2019 and 2026 to reach a valuation of US$ XX million/billion by the end of 2026. In 2018, the global Stem Cell Assay market attained a valuation of US$_ million/billion. The market researchers deeply analyze the global Stem Cell Assay industry landscape and the future prospects it is anticipated to create.

This publication includes key segmentations of the global Stem Cell Assay market on the basis of product, application, and geography (country/region). Each segment included in the report is studied in relation to different factors such as consumption, market share, value, growth rate, and production.

Get Sample Copy of This Report:https://www.qyresearch.com/sample-form/form/2321931/global-stem-cell-assay-market

The comparative results provided in the report allow readers to understand the difference between players and how they are competing against each other. The research study gives a detailed view of current and future trends and opportunities of the global Stem Cell Assay market. Market dynamics such as drivers and restraints are explained in the most detailed and easiest manner possible with the use of tables and graphs. Interested parties are expected to find important recommendations to improve their business in the global Stem Cell Assay market.

Readers can understand the overall profitability margin and sales volume of various products studied in the report. The report also provides the forecasted as well as historical annual growth rate and market share of the products offered in the global Stem Cell Assay market. The study on end-use application of products helps to understand the market growth of the products in terms of sales.

Global Stem Cell Assay Market by Product: , Adult Stem Cells, Human Embryonic Stem Cells (hESCs)

Global Stem Cell Assay Market by Application: , Regenerative Medicine, Drug Discovery & Development, Clinical Research

The report also focuses on the geographical analysis of the global Stem Cell Assay market, where important regions and countries are studied in great detail.

Global Stem Cell Assay Market by Geography:

Methodology

Our analysts have created the report with the use of advanced primary and secondary research methodologies.

As part of primary research, they have conducted interviews with important industry leaders and focused on market understanding and competitive analysis by reviewing relevant documents, press releases, annual reports, and key products.

For secondary research, they have taken into account the statistical data from agencies, trade associations, and government websites, internet sources, technical writings, and recent trade information.

Enquire For Customization in the Report:https://www.qyresearch.com/customize-request/form/2321931/global-stem-cell-assay-market

Key questions answered in the report:

Get Full Report in your Inbox within 24 Hours at USD(3350): https://www.qyresearch.com/settlement/pre/6f72e898951bf47588dbbb264286a85a,0,1,global-stem-cell-assay-market

Table Of Contents:

1 Market Overview of Stem Cell Assay1.1 Stem Cell Assay Market Overview1.1.1 Stem Cell Assay Product Scope1.1.2 Market Status and Outlook1.2 Global Stem Cell Assay Market Size Overview by Region 2015 VS 2020 VS 20261.3 Global Stem Cell Assay Market Size by Region (2015-2026)1.4 Global Stem Cell Assay Historic Market Size by Region (2015-2020)1.5 Global Stem Cell Assay Market Size Forecast by Region (2021-2026)1.6 Key Regions, Stem Cell Assay Market Size YoY Growth (2015-2026)1.6.1 North America Stem Cell Assay Market Size YoY Growth (2015-2026)1.6.2 Europe Stem Cell Assay Market Size YoY Growth (2015-2026)1.6.3 Asia-Pacific Stem Cell Assay Market Size YoY Growth (2015-2026)1.6.4 Latin America Stem Cell Assay Market Size YoY Growth (2015-2026)1.6.5 Middle East & Africa Stem Cell Assay Market Size YoY Growth (2015-2026) 2 Stem Cell Assay Market Overview by Type2.1 Global Stem Cell Assay Market Size by Type: 2015 VS 2020 VS 20262.2 Global Stem Cell Assay Historic Market Size by Type (2015-2020)2.3 Global Stem Cell Assay Forecasted Market Size by Type (2021-2026)2.4 Adult Stem Cells2.5 Human Embryonic Stem Cells (hESCs) 3 Stem Cell Assay Market Overview by Application3.1 Global Stem Cell Assay Market Size by Application: 2015 VS 2020 VS 20263.2 Global Stem Cell Assay Historic Market Size by Application (2015-2020)3.3 Global Stem Cell Assay Forecasted Market Size by Application (2021-2026)3.4 Regenerative Medicine3.5 Drug Discovery & Development3.6 Clinical Research 4 Global Stem Cell Assay Competition Analysis by Players4.1 Global Stem Cell Assay Market Size by Players (2015-2020)4.2 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Stem Cell Assay as of 2019)4.3 Date of Key Manufacturers Enter into Stem Cell Assay Market4.4 Global Top Players Stem Cell Assay Headquarters and Area Served4.5 Key Players Stem Cell Assay Product Solution and Service4.6 Competitive Status4.6.1 Stem Cell Assay Market Concentration Rate4.6.2 Mergers & Acquisitions, Expansion Plans 5 Company (Top Players) Profiles and Key Data5.1 Merck5.1.1 Merck Profile5.1.2 Merck Main Business5.1.3 Merck Stem Cell Assay Products, Services and Solutions5.1.4 Merck Stem Cell Assay Revenue (US$ Million) & (2015-2020)5.1.5 Merck Recent Developments5.2 Thermo Fisher Scientific5.2.1 Thermo Fisher Scientific Profile5.2.2 Thermo Fisher Scientific Main Business5.2.3 Thermo Fisher Scientific Stem Cell Assay Products, Services and Solutions5.2.4 Thermo Fisher Scientific Stem Cell Assay Revenue (US$ Million) & (2015-2020)5.2.5 Thermo Fisher Scientific Recent Developments5.3 GE Healthcare5.5.1 GE Healthcare Profile5.3.2 GE Healthcare Main Business5.3.3 GE Healthcare Stem Cell Assay Products, Services and Solutions5.3.4 GE Healthcare Stem Cell Assay Revenue (US$ Million) & (2015-2020)5.3.5 Agilent Technologies Recent Developments5.4 Agilent Technologies5.4.1 Agilent Technologies Profile5.4.2 Agilent Technologies Main Business5.4.3 Agilent Technologies Stem Cell Assay Products, Services and Solutions5.4.4 Agilent Technologies Stem Cell Assay Revenue (US$ Million) & (2015-2020)5.4.5 Agilent Technologies Recent Developments5.5 Bio-Rad Laboratories5.5.1 Bio-Rad Laboratories Profile5.5.2 Bio-Rad Laboratories Main Business5.5.3 Bio-Rad Laboratories Stem Cell Assay Products, Services and Solutions5.5.4 Bio-Rad Laboratories Stem Cell Assay Revenue (US$ Million) & (2015-2020)5.5.5 Bio-Rad Laboratories Recent Developments5.6 Promega5.6.1 Promega Profile5.6.2 Promega Main Business5.6.3 Promega Stem Cell Assay Products, Services and Solutions5.6.4 Promega Stem Cell Assay Revenue (US$ Million) & (2015-2020)5.6.5 Promega Recent Developments5.7 Cell Biolabs5.7.1 Cell Biolabs Profile5.7.2 Cell Biolabs Main Business5.7.3 Cell Biolabs Stem Cell Assay Products, Services and Solutions5.7.4 Cell Biolabs Stem Cell Assay Revenue (US$ Million) & (2015-2020)5.7.5 Cell Biolabs Recent Developments5.8 PerkinElmer5.8.1 PerkinElmer Profile5.8.2 PerkinElmer Main Business5.8.3 PerkinElmer Stem Cell Assay Products, Services and Solutions5.8.4 PerkinElmer Stem Cell Assay Revenue (US$ Million) & (2015-2020)5.8.5 PerkinElmer Recent Developments5.9 Miltenyi Biotec5.9.1 Miltenyi Biotec Profile5.9.2 Miltenyi Biotec Main Business5.9.3 Miltenyi Biotec Stem Cell Assay Products, Services and Solutions5.9.4 Miltenyi Biotec Stem Cell Assay Revenue (US$ Million) & (2015-2020)5.9.5 Miltenyi Biotec Recent Developments5.10 HemoGenix5.10.1 HemoGenix Profile5.10.2 HemoGenix Main Business5.10.3 HemoGenix Stem Cell Assay Products, Services and Solutions5.10.4 HemoGenix Stem Cell Assay Revenue (US$ Million) & (2015-2020)5.10.5 HemoGenix Recent Developments5.11 Bio-Techne5.11.1 Bio-Techne Profile5.11.2 Bio-Techne Main Business5.11.3 Bio-Techne Stem Cell Assay Products, Services and Solutions5.11.4 Bio-Techne Stem Cell Assay Revenue (US$ Million) & (2015-2020)5.11.5 Bio-Techne Recent Developments5.12 STEMCELL5.12.1 STEMCELL Profile5.12.2 STEMCELL Main Business5.12.3 STEMCELL Stem Cell Assay Products, Services and Solutions5.12.4 STEMCELL Stem Cell Assay Revenue (US$ Million) & (2015-2020)5.12.5 STEMCELL Recent Developments 6 North America6.1 North America Stem Cell Assay Market Size by Country6.2 United States6.3 Canada 7 Europe7.1 Europe Stem Cell Assay Market Size by Country7.2 Germany7.3 France7.4 U.K.7.5 Italy7.6 Russia7.7 Nordic7.8 Rest of Europe 8 Asia-Pacific8.1 Asia-Pacific Stem Cell Assay Market Size by Region8.2 China8.3 Japan8.4 South Korea8.5 Southeast Asia8.6 India8.7 Australia8.8 Rest of Asia-Pacific 9 Latin America9.1 Latin America Stem Cell Assay Market Size by Country9.2 Mexico9.3 Brazil9.4 Rest of Latin America 10 Middle East & Africa10.1 Middle East & Africa Stem Cell Assay Market Size by Country10.2 Turkey10.3 Saudi Arabia10.4 UAE10.5 Rest of Middle East & Africa 11 Stem Cell Assay Market Dynamics11.1 Industry Trends11.2 Market Drivers11.3 Market Challenges11.4 Market Restraints 12 Research Finding /Conclusion 13 Methodology and Data Source 13.1 Methodology/Research Approach13.1.1 Research Programs/Design13.1.2 Market Size Estimation13.1.3 Market Breakdown and Data Triangulation13.2 Data Source13.2.1 Secondary Sources13.2.2 Primary Sources13.3 Disclaimer13.4 Author List

About Us:

QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.

Read more:

Stem Cell Assay to Register Substantial Expansion by 2026| Merck, Thermo Fisher Scientific, GE Healthcare - The Haitian-Caribbean News Network

Read more
Stem Cell Medical Research to Expand in California Following Passage of Prop. 14 – Times of San Diego

Share This Article:A stem cell research center at UC Davis. Courtesy California Institute for Regenerative MedicineBy Barbara Feder Ostrov | CalMatters

Californias stem cell research agency was supposed to be winding down its operations right about now, after a 16-year run and hundreds of millions in grants to scientists researching cutting-edge treatments for diabetes, cancer, Alzheimers and other diseases.

Support Times of San Diego's growthwith a small monthly contribution

Instead, the taxpayer-supported California Institute for Regenerative Medicine will get a $5.5 billion reboot after voters earlier this month narrowly passed the Proposition 14bond measure. The overall cost of the bonds with interest will total about $7.8 billion.

Were thrilled that California voters saw fit to continue the work weve done, said Jonathan Thomas, chair of the agencys governing board. California has always had a frontier mentality and a love for the cutting edge, and the work that CIRM has done has put it on the very forefront of regenerative medicine.

Even with Californias economy in a coronavirus-induced tailspin and somescientists arguingthat stem cell research no longer needs taxpayer support,Prop. 14passed with 51 percent of the vote after well-financed supporters pourednearly $21 millioninto the Yes on 14 campaign. The measure was essentially a rerun of Proposition 71, which California voters approved in 2004 after a since-revoked federal ban on embryonic stem cell research.

The cash infusion is expected to keep the institute running for another 10 to 15 years, although the agency will see some significant changes under Prop. 14.

The institute also must contend with longstanding concerns over conflicts of interest that have dogged it since its inception, observers say. About 80% of the money distributed has gone to universities and companies tied to agency board members, according to an analysisby longtime agency watchdog David Jensen, a former Sacramento Bee journalist who runs theCalifornia Stem Cell Reportblog and wrote abookon the institute.

Prop. 14 allows the agency to fund a wider array of research projects even some that dont involve stem cells, but instead are related to genetics, personalized medicine and aging.

Thats necessary because the field has evolved, said Paul Knoepfler, a UC Davis professor of cell biology who studies the role of stem cells in cancer and writes a stem cell blog. He received a 2009 grant from the institute.

Stem cells are interesting and important, but there are going to be a lot of new therapies in the next 10 years that are not stem-cell centric, Knoepfler said.

Other changes for the agency include:

Ysabel Duron, who joined the institutes board late last year, said she sees her role as promoting equity in opportunities for both researchers and patients and ensuring that treatments resulting from the research can benefit all Californians.

Researchers in particular need to boost the diversity of patients in their clinical trials and do a better job communicating the value of their work to the public, Duron said, noting that nearly 40% of Californians are Latino.

We need to keep researchers feet to the fire, said Duron, a former television journalist and founder of the Latino Cancer Institute. They need to show us a plan and we need to reward them.

To date, the agency has funded 64 clinical trials of treatments for many types of cancer, sickle cell disease, spinal cord injuries, diabetes, kidney disease and amyotrophic lateral sclerosis, commonlyknown as Lou Gehrigs disease.But the most advanced trials involve therapies for relatively rare conditions, such asSevere Combined Immunodeficiency known as the bubble baby disease, Jensen noted. That therapy is being reviewed by the FDA but has not yet been approved.

Cancer, heart disease these are the big killers. Thats what most people are interested in, Jensen said. You can fund something for a rare disease, but that doesnt affect the majority of Californians.

And, Jensen asks, what will happen after the agency runs out of money again? Will taxpayers once again be asked to refill its coffers? There was hope when the agency began that revenues from successful treatments would sustain its grant-making in the years to come, but the institute has only received a few hundred thousand dollars, not nearly enough to become self-sustaining without taxpayer support, according to theLegislative Analysts Office.

The sustainability issue is important and its hard to address, Jensen said. The money doesnt last forever.

Stem Cell Medical Research to Expand in California Following Passage of Prop. 14 was last modified: November 27th, 2020 by Editor

>> Subscribe to Times of San Diegos free daily email newsletter! Click here

Continued here:

Stem Cell Medical Research to Expand in California Following Passage of Prop. 14 - Times of San Diego

Read more
Autism genes affect development of neurons and glia – Spectrum

Single-cell search: Researchers mutated autism-linked genes in developing mouse embryos using a viral technique. They analyzed the cells carrying mutations (pink) when the mice were 7 days old.

Mutations in a set of 35 genes linked to autism affect both neurons and glial cells in developing mice, according to a study published today. The study is the first to screen multiple autism-gene mutations, one by one, in living mice and analyze their effects in individual brain cells.

About 100 genes have been strongly linked to autism, and sequencing efforts continue to uncover more. But how mutations in each of these genes affect brain development remains largely unknown. Although researchers have investigated the molecular effects of just a few genes, testing all of them individually is a daunting task.

In the new work, researchers built on a technique called Perturb-seq, developed in 2016. This technique mutates the genome in individual cells using CRISPR technology and then sequences the RNA in each cell to determine how the mutation changed it.

Perturb-seq has been used in cells grown in a dish, says Paola Arlotta, professor of stem cell and regenerative biology at Harvard University, who co-led the work, but this is the first time that it is applied in an intact, living and developing organism.

Arlotta and her colleagues injected viruses carrying CRISPR gene-editing machinery into 12-day-old mouse embryos. They used just enough virus to cause mutations in 1 out of every 1,000 stem cells in the embryonic brain.

When the pups were 7 days old, the researchers sequenced the RNA in five different cell types in the pups brains: three types of neurons and two types of glial cells. They then identified groups of mutations in which gene expression had changed in similar ways.

Mutations in several of the autism-linked genes affect common sets of related genes and multiple cell types, they found.

The approach allows researchers to study how different autism-linked genes might converge on similar developmental pathways, says Xin Jin, a junior fellow at Harvard who worked on the study.

The researchers plan to expand the number of genes that the technique can mutate at once, Arlotta says. They also plan to apply it to lab-grown human brain cells that form clusters called organoids, to test whether genes affect development comparably in mice and people.

View post:

Autism genes affect development of neurons and glia - Spectrum

Read more
Stem Cell Therapy Global Market Report 2020-30: Covid 19 Growth and Change – Yahoo Finance UK

Globe Newswire

Dublin, Nov. 26, 2020 (GLOBE NEWSWIRE) -- The "Interdental Cleaning Products - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Amid the COVID-19 crisis, the global market for Interdental Cleaning Products estimated at US$3.4 Billion in the year 2020, is projected to reach a revised size of US$4.2 Billion by 2027, growing at a CAGR of 2.9% over the analysis period 2020-2027. Interdental Brush, one of the segments analyzed in the report, is projected to record a 3.1% CAGR and reach US$1.3 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Toothpicks segment is readjusted to a revised 3.5% CAGR for the next 7-year period.The U. S. Market is Estimated at $922.4 Million, While China is Forecast to Grow at 5.4% CAGRThe Interdental Cleaning Products market in the U. S. is estimated at US$922.4 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$851.5 Million by the year 2027 trailing a CAGR of 5.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 0.8% and 2.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 1.4% CAGR.Dental Floss Segment to Record 2.6% CAGRIn the global Dental Floss segment, USA, Canada, Japan, China and Europe will drive the 2.2% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$485.1 Million in the year 2020 will reach a projected size of US$563.5 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$578 Million by the year 2027, while Latin America will expand at a 3.3% CAGR through the analysis period. We bring years of research experience to this 8th edition of our report. The 191-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.Competitors identified in this market include, among others: Colgate-Palmolive CompanyCuraden USA, Inc.Jacks BS Singapore Pte. Ltd. - DentalproKoninklijke Philips N. V.Lion CorporationM+C SCHIFFER GmbHNaisen Caring Co., Ltd.Oral-BPikstersPrestige Consumer Healthcare, Inc. - Den TekSunstar Americas, Inc.TRISA AG Key Topics Covered: I. INTRODUCTION, METHODOLOGY & REPORT SCOPEII. EXECUTIVE SUMMARY1. MARKET OVERVIEW Global Competitor Market SharesInterdental Cleaning Products Competitor Market Share Scenario Worldwide (in %): 2019 & 2025Impact of Covid-19 and a Looming Global Recession 2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS4. GLOBAL MARKET PERSPECTIVEIII. MARKET ANALYSISGEOGRAPHIC MARKET ANALYSISIV. COMPETITION For more information about this report visit https://www.researchandmarkets.com/r/vbn3rm About ResearchAndMarkets.com ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

Continue reading here:

Stem Cell Therapy Global Market Report 2020-30: Covid 19 Growth and Change - Yahoo Finance UK

Read more